Biopharmaceutical Fermentation Systems Market Report, 2032

Biopharmaceutical Fermentation Systems Market – Product Type (Upstream [Bioreactor, Bioprocess Analyzer], Downstream [Chromatography, Filtration]), Application (Recombinant Proteins, Antibiotics, Probiotics), End User – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp;Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp;Research design

1.2.1&nbsp;&nbsp;&nbsp;Research approach

1.2.2&nbsp;&nbsp;&nbsp;Data collection methods

1.3&nbsp;&nbsp;&nbsp;Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp;Base year calculation

1.3.2&nbsp;&nbsp;&nbsp;Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp;Forecast model

1.5&nbsp;&nbsp;&nbsp;Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp;Primary sources

1.5.2&nbsp;&nbsp;&nbsp;Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp;Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp;Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp;Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp;Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing demand for biopharmaceuticals

3.2.1.2&nbsp;&nbsp;&nbsp; Growing investments for developing new biopharmaceuticals and biosimilars

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing regulatory approvals for biopharmaceutical products

3.2.1.4&nbsp;&nbsp;&nbsp; Growing adoption of single use fermenters

3.2.2&nbsp;&nbsp;&nbsp;Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Requirements for high initial capital investments

3.2.2.2&nbsp;&nbsp;&nbsp; Issues related to extractables and leachables

3.3&nbsp;&nbsp;&nbsp;Growth potential analysis

3.4&nbsp;&nbsp;&nbsp;Regulatory landscape

3.5&nbsp;&nbsp;&nbsp;Future market trends

3.6&nbsp;&nbsp;&nbsp;Gap analysis

3.7&nbsp;&nbsp;&nbsp;Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp;PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp;Introduction

4.2&nbsp;&nbsp;&nbsp;Company market share analysis

4.3&nbsp;&nbsp;&nbsp;Company matrix analysis

4.4&nbsp;&nbsp;&nbsp;Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp;Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp;Key trends

5.2&nbsp;&nbsp;&nbsp;Upstream products

5.2.1&nbsp;&nbsp;&nbsp;Bioreactors/fermenters

5.2.2&nbsp;&nbsp;&nbsp;Bioprocess analyzers

5.2.3&nbsp;&nbsp;&nbsp;Process monitoring systems

5.2.4&nbsp;&nbsp;&nbsp;Other upstream products

5.3&nbsp;&nbsp;&nbsp;Downstream products

5.3.1&nbsp;&nbsp;&nbsp;Filtration &amp; separation

5.3.2&nbsp;&nbsp;&nbsp;Chromatography

5.3.3&nbsp;&nbsp;&nbsp;Consumables &amp; accessories

5.3.4&nbsp;&nbsp;&nbsp;Other downstream products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp;Key trends

6.2&nbsp;&nbsp;&nbsp;Recombinant proteins

6.3&nbsp;&nbsp;&nbsp;Antibiotics

6.4&nbsp;&nbsp;&nbsp;Probiotics

6.5&nbsp;&nbsp;&nbsp;Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End User, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp;Key trends

7.2&nbsp;&nbsp;&nbsp;Biopharmaceutical companies

7.3&nbsp;&nbsp;&nbsp;Contract research organizations

7.4&nbsp;&nbsp;&nbsp;Academic research institutes

7.5&nbsp;&nbsp;&nbsp;Other end users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp;Key trends

8.2&nbsp;&nbsp;&nbsp;North America

8.2.1&nbsp;&nbsp;&nbsp;U.S.

8.2.2&nbsp;&nbsp;&nbsp;Canada

8.3&nbsp;&nbsp;&nbsp;Europe

8.3.1&nbsp;&nbsp;&nbsp;Germany

8.3.2&nbsp;&nbsp;&nbsp;UK

8.3.3&nbsp;&nbsp;&nbsp;France

8.3.4&nbsp;&nbsp;&nbsp;Spain

8.3.5&nbsp;&nbsp;&nbsp;Italy

8.3.6&nbsp;&nbsp;&nbsp;Netherlands

8.3.7&nbsp;&nbsp;&nbsp;Rest of Europe

8.4&nbsp;&nbsp;&nbsp;Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp;China

8.4.2&nbsp;&nbsp;&nbsp;Japan

8.4.3&nbsp;&nbsp;&nbsp;India

8.4.4&nbsp;&nbsp;&nbsp;Australia

8.4.5&nbsp;&nbsp;&nbsp;South Korea

8.4.6&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp;Latin America

8.5.1&nbsp;&nbsp;&nbsp;Brazil

8.5.2&nbsp;&nbsp;&nbsp;Mexico

8.5.3&nbsp;&nbsp;&nbsp;Rest of Latin America

8.6&nbsp;&nbsp;&nbsp;Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp;South Africa

8.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp;UAE

8.6.4&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles 

9.1&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc.

9.2&nbsp;&nbsp;&nbsp; Becton, Dickinson and Company

9.3&nbsp;&nbsp;&nbsp; Bioengineering AG

9.4&nbsp;&nbsp;&nbsp; Cellexus Limited

9.5&nbsp;&nbsp;&nbsp; Danaher Corporation

9.6&nbsp;&nbsp;&nbsp; Eppendorf AG

9.7&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

9.8&nbsp;&nbsp;&nbsp; GE HealthCare Technologies, Inc.

9.9&nbsp;&nbsp;&nbsp; Getinge Group

9.10&nbsp;&nbsp;&nbsp; Lonza Group AG

9.11&nbsp;&nbsp;&nbsp; Merck KGaA

9.12&nbsp;&nbsp;&nbsp; Nova Biomedicals

9.13&nbsp;&nbsp;&nbsp; Sartorius Stedim Biotech

9.14&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

9.15&nbsp;&nbsp;&nbsp; ZETA

&nbsp;&nbsp;

Biopharmaceutical Fermentation Systems Market

Get a free sample of this report